Effect of Flying at High Altitude on Early Exposure of Paracetamol in Humans

Abstract

Pharmacokinetics of paracetamol (APAP) was studied on-board during an air flight and compared to those on ground after 500 mg oral dose in 20 healthy human volunteer in parallel design study. Saliva samples were obtained every 15 min up to 2 h after dosing. Pharmacokinetic parameters were calculated by non compartmental analysis and one compartment models using Winnonlin program V5.2. Results have showed that on-board to ground ratios for area under curves AUC_0→1, AUC_0→2, time to reach maximum saliva concentration T_max, absorption rate constant Ka and maximum saliva concentration C_max were 0.62, 0.38, 1.01, 0.81 and 0.79 respectively. Effective membrane permeability coefficients were optimized by Nelder-Mead algorithm using Simcyp program V13. This showed similar rate of absorption and early exposure up to one hour, and lower bioavailability after 1 h on-board. This can be explained by the increased liver blood flow at high altitude that led to increased liver metabolism on-board. However, APAP elimination parameters were not calculated due to short sampling time. This suggests a need for dose adjustment on-board during long air flights, especially for narrow therapeutic index drugs with flow limited metabolism.

Key words

high altitude - paracetamol - early exposure - saliva sampling

• References

• 1 Macdonald JH, Oliver SJ, Hillyer K. et al. Body composition at high altitude: a randomized placebo-controlled trial of dietary carbohydrate supplementation. Am J Clin Nutr 2009; 90: 1193-1202
• 2 Mieske K, Flaherty G, O’Brien T. Journeys to High Altitude—Risks and Recommendations for Travelers with Preexisting Medical Conditions. Journal of Travel Medicine 2010; Volume 17 Issue 1 48-62
• 3 Amidon GL, DeBrincat G, Najib NM. Effects of gravity on gastric emptying, intestinal transit and drug absorption. J Clin Pharmacol. 1991; 31: 968-973
• 4 Gandia P, Bareille MP, Saivin S. et al. Influence of simulated weightlessness on the Oral pharmacokinetics of paracetamol as a gastric emptying Probe in man: a plasma and a saliva study. J Clin Pharmacol 2003; 1235-1243
• 5 Ritschel WA, Paulos C, Aquiles A. et al. Pharmacokinetics of Acetazolamide in Healthy Volunteers after Short- and Long-Term Exposure to High Altitude. The Journal of Clinical Pharmacology 1998; 38: 533-539
• 6 Ritschel WA, Paulos C, Aquiles A. et al. Pharmacokinetics of Meperidine in Healthy Volunteers after Short- and Long-Term Exposure to High Altitude. The Journal of Clinical Pharmacology 1996; 36: 610-616
• 7 Muntingh GL. Drugs in Aviation - A Review. SA Fam Pract 2007; 49: 44-49
• 8 Kamali F, Edwards C, Rawlins MD. The effect of pirenzepine on gastric emptying and salivary flow rate: constraints on the use of saliva paracetamol concentrations for the determination of paracetamol pharmacokinetics. Br. J. clin. Pharmac 1992; 33: 309-312
• 9 Kalson NS, Hext F, Davies AJ. et al. Do changes in gastrointestinal blood flow explain high-altitude anorexia?. Eur J Clin Invest 2010; 40: 735-741
• 10 Ramsoe K, Jarnum S, Preisig R. et al. Liver function and blood flow at high altitude. J Appl Physiol 1970; 28: 725-727
• 11 Luks AM, Swenson ER. Evaluating the Risks of High Altitude Travel in Chronic Liver Disease Patients. high altitude medicine & biology 2015; Volume 16 Number 00 1-9
• 12 Takamatsu N, Kim ON, Welage LS. et al. Human jejunal permeability of two polar drugs: cimetidine and ranitidine. Pharm Res 2001; 18: 742-744
• 13 http://www.micromedexsolutions.com